US5736155A
(en)
*
|
1984-08-08 |
1998-04-07 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
WO1986003938A1
(en)
*
|
1985-01-11 |
1986-07-17 |
The Regents Of The University Of California |
Method for preserving liposomes
|
US4857319A
(en)
*
|
1985-01-11 |
1989-08-15 |
The Regents Of The University Of California |
Method for preserving liposomes
|
US5171578A
(en)
*
|
1985-06-26 |
1992-12-15 |
The Liposome Company, Inc. |
Composition for targeting, storing and loading of liposomes
|
US5059421A
(en)
*
|
1985-07-26 |
1991-10-22 |
The Liposome Company, Inc. |
Preparation of targeted liposome systems of a defined size distribution
|
US5041278A
(en)
*
|
1985-10-15 |
1991-08-20 |
The Liposome Company, Inc. |
Alpha tocopherol-based vesicles
|
GB8604983D0
(en)
*
|
1986-02-28 |
1986-04-09 |
Biocompatibles Ltd |
Protein preservation
|
US5252263A
(en)
*
|
1986-06-16 |
1993-10-12 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
US5204112A
(en)
*
|
1986-06-16 |
1993-04-20 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
US5043107A
(en)
*
|
1986-08-21 |
1991-08-27 |
Vestar Research, Inc. |
Preparation small unilamellar vesicles including polyene antifungal antibiotics
|
IE60901B1
(en)
*
|
1986-08-21 |
1994-08-24 |
Vestar Inc |
Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
|
US5755788A
(en)
*
|
1987-02-19 |
1998-05-26 |
Rutgers, The State University |
Prosthesis and implants having liposomes bound thereto and methods of preparation
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
US4963297A
(en)
*
|
1987-12-22 |
1990-10-16 |
The Liposome Company, Inc. |
Spontaneous vesticulation of multilamellar liposomes
|
US5616334A
(en)
*
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
US6406713B1
(en)
|
1987-03-05 |
2002-06-18 |
The Liposome Company, Inc. |
Methods of preparing low-toxicity drug-lipid complexes
|
US5262168A
(en)
*
|
1987-05-22 |
1993-11-16 |
The Liposome Company, Inc. |
Prostaglandin-lipid formulations
|
JP2780755B2
(ja)
*
|
1987-05-22 |
1998-07-30 |
ザ リポソーム カンパニー,インコーポレイテッド |
プロスタグランジン‐脂質製剤
|
AU617678B2
(en)
*
|
1987-05-22 |
1991-12-05 |
Liposome Company, Inc., The |
Prostaglandin-lipid formulations
|
US5811118A
(en)
*
|
1987-05-22 |
1998-09-22 |
The Liposome Company, Inc. |
Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
|
US5925375A
(en)
*
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
GB8715238D0
(en)
*
|
1987-06-29 |
1987-08-05 |
Quadrant Bioresources Ltd |
Food process
|
US5830498A
(en)
*
|
1987-10-16 |
1998-11-03 |
Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
US5178875A
(en)
*
|
1991-01-14 |
1993-01-12 |
The Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
MX9203804A
(es)
*
|
1987-10-19 |
1992-07-01 |
Liposome Co Inc |
Sistemas farmaceuticos a base de tocoferol.
|
AU598958B2
(en)
*
|
1987-11-12 |
1990-07-05 |
Vestar, Inc. |
Improved amphotericin b liposome preparation
|
US4946683A
(en)
*
|
1987-11-18 |
1990-08-07 |
Vestar, Inc. |
Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
|
EP0319638A1
(de)
*
|
1987-12-08 |
1989-06-14 |
Estee Lauder Inc. |
Liposome enthaltende Kosmetika und Arzneimittel sowie Verfahren zur Anwendung solcher Mittel
|
US5948441A
(en)
*
|
1988-03-07 |
1999-09-07 |
The Liposome Company, Inc. |
Method for size separation of particles
|
AU612285B2
(en)
*
|
1988-10-05 |
1991-07-04 |
Vestar, Inc. |
Method of making liposomes with improved stability during drying
|
ES2085920T3
(es)
*
|
1989-06-23 |
1996-06-16 |
Liposome Co Inc |
Liposomas dirigidos y metodos de acoplamiento liposoma-proteina.
|
US5104661A
(en)
*
|
1989-08-14 |
1992-04-14 |
Technology Unlimited, Inc. |
Reverse loading of liposomes
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
US5230882A
(en)
*
|
1989-12-22 |
1993-07-27 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5228446A
(en)
*
|
1989-12-22 |
1993-07-20 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5088499A
(en)
*
|
1989-12-22 |
1992-02-18 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US5542935A
(en)
*
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5334381A
(en)
*
|
1989-12-22 |
1994-08-02 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US5882678A
(en)
*
|
1990-01-12 |
1999-03-16 |
The Liposome Co, Inc. |
Interdigitation-fusion liposomes containing arachidonic acid metabolites
|
DE69120089T2
(de)
*
|
1990-07-31 |
1996-12-12 |
Liposome Co Inc |
Anhäufung von aminosäuren und peptiden in liposomen
|
CA2047969A1
(en)
*
|
1990-08-17 |
1992-02-18 |
Thomas D. Madden |
Benzoporphyrin vesicles
|
US5885260A
(en)
|
1991-05-30 |
1999-03-23 |
Mehl, Sr.; Thomas L. |
Freeze-dried liposome delivery system for application of skin treatment agents
|
US5325860A
(en)
*
|
1991-11-08 |
1994-07-05 |
Mayo Foundation For Medical Education And Research |
Ultrasonic and interventional catheter and method
|
CA2087902C
(en)
*
|
1992-02-05 |
2006-10-17 |
Narendra Raghunathji Desai |
Liposome compositions of porphyrin photosensitizers
|
US6890555B1
(en)
|
1992-02-05 |
2005-05-10 |
Qlt, Inc. |
Liposome compositions of porphyrin photosensitizers
|
US6005100A
(en)
*
|
1992-12-02 |
1999-12-21 |
Kabushiki Kaisha Hayashibara Seitbutsu Kagaku Kenkyujo |
Trehalose composition for prolonging product shelf life
|
JP3168550B2
(ja)
*
|
1992-12-02 |
2001-05-21 |
株式会社林原生物化学研究所 |
脱水剤およびそれを用いる含水物の脱水方法並びにその方法で得られる脱水物品
|
JP3329554B2
(ja)
*
|
1993-03-10 |
2002-09-30 |
千葉製粉株式会社 |
乾燥小胞体
|
AU6833994A
(en)
*
|
1993-05-17 |
1994-12-12 |
Liposome Company, Inc., The |
Incorporation of taxol into liposomes and gels
|
US5576016A
(en)
*
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
DE1118326T1
(de)
*
|
1993-05-21 |
2002-04-18 |
The Liposome Co., Inc. |
Reduzierung von durch Liposomen induzierten physiologischen Gegenreaktionen
|
US6004534A
(en)
*
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
WO1995003035A1
(en)
*
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
GB9320668D0
(en)
|
1993-10-07 |
1993-11-24 |
Secr Defence |
Liposomes containing particulare materials
|
JP3187622B2
(ja)
|
1993-10-07 |
2001-07-11 |
カネボウ株式会社 |
リポソーム
|
WO1995011670A1
(en)
*
|
1993-10-25 |
1995-05-04 |
The Liposome Company, Inc. |
Liposomal defensins
|
JPH10508578A
(ja)
*
|
1994-09-23 |
1998-08-25 |
ザ リポソーム カンパニー、インコーポレーテッド |
凍結乾燥リポソーム生成物の製造方法
|
US5820873A
(en)
*
|
1994-09-30 |
1998-10-13 |
The University Of British Columbia |
Polyethylene glycol modified ceramide lipids and liposome uses thereof
|
US6387399B1
(en)
|
1994-12-02 |
2002-05-14 |
The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration |
Microencapsulated bioactive agents and method of making
|
US6071535A
(en)
*
|
1996-01-31 |
2000-06-06 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US5874105A
(en)
*
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US6183774B1
(en)
|
1996-01-31 |
2001-02-06 |
Collaborative Laboratories, Inc. |
Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
|
US6165442A
(en)
*
|
1996-02-19 |
2000-12-26 |
Nycomed Imaging As |
Thermally stabilized ultrasound contrast agent
|
US6207185B1
(en)
|
1996-03-22 |
2001-03-27 |
Bio-Sphere Technology |
Method for inducing a systemic immune response to an HIV antigen
|
US6117449A
(en)
*
|
1996-03-22 |
2000-09-12 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to a hepatitis antigen
|
US6015576A
(en)
*
|
1997-08-29 |
2000-01-18 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to an antigen
|
ATE405664T1
(de)
*
|
1996-03-28 |
2008-09-15 |
Univ Boston |
Methoden zur modulation der melaninsynthese
|
CA2202103C
(en)
*
|
1996-04-11 |
2007-01-09 |
Toshiaki Tagawa |
Method for preparing closed vesicles
|
US6093816A
(en)
*
|
1996-06-27 |
2000-07-25 |
Isis Pharmaceuticals, Inc. |
Cationic lipids
|
DE19639811A1
(de)
*
|
1996-09-27 |
1998-04-02 |
Artur Herzog Dr Mesmer |
Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln
|
US5837282A
(en)
*
|
1996-10-30 |
1998-11-17 |
University Of British Columbia |
Ionophore-mediated liposome loading
|
US5935572A
(en)
*
|
1997-01-10 |
1999-08-10 |
Collaborative Laboratories, Inc. |
Composition containing protease separate from glycosidase for removing nits in treating lice infestation
|
US6060082A
(en)
*
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
US6004925A
(en)
*
|
1997-09-29 |
1999-12-21 |
J. L. Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
US6046166A
(en)
*
|
1997-09-29 |
2000-04-04 |
Jean-Louis Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
US6037323A
(en)
*
|
1997-09-29 |
2000-03-14 |
Jean-Louis Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
US6518412B1
(en)
*
|
1997-09-29 |
2003-02-11 |
Jean-Louis Dasseux |
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
US6287590B1
(en)
*
|
1997-10-02 |
2001-09-11 |
Esperion Therapeutics, Inc. |
Peptide/lipid complex formation by co-lyophilization
|
US6734171B1
(en)
|
1997-10-10 |
2004-05-11 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating nucleic acids in lipid bilayers
|
US20010003580A1
(en)
*
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
IL138672A0
(en)
*
|
1998-03-31 |
2001-10-31 |
Yissum Res Dev Co |
Liposomal bupivacaine compositions and methods of preparation
|
US20010016346A1
(en)
*
|
1998-06-09 |
2001-08-23 |
Joseph P. Noel |
Pedtidyl-prolyl cis-trans isomerase inhibitors and uses therefore
|
GB9813100D0
(en)
*
|
1998-06-18 |
1998-08-19 |
Secr Defence |
Method of forming liposomes
|
WO2000053177A1
(fr)
|
1999-03-11 |
2000-09-14 |
Fujisawa Pharmaceutical Co., Ltd. |
Preparations liposomiques
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
CA2375532A1
(en)
*
|
1999-06-23 |
2000-12-28 |
Cornell Research Foundation, Inc. |
Dehydration/rehydration of marked liposomes on a test device
|
GB9916316D0
(en)
*
|
1999-07-12 |
1999-09-15 |
Quadrant Holdings Cambridge |
Dry powder compositions
|
EP1196144B1
(de)
*
|
1999-07-16 |
2004-09-22 |
Alza Corporation |
Gegen gefrier/auftau-schaden resistente liposomzusammensetzung
|
EP1221938A2
(de)
*
|
1999-10-18 |
2002-07-17 |
Fujisawa Pharmaceutical Co., Ltd. |
Verfahren zur hestellung einer liposomzusammensetzung
|
US6710038B1
(en)
|
1999-12-14 |
2004-03-23 |
Kibun Food Chemifa Co., Ltd. |
Emulsification method using propylene glycol hyaluronate
|
AU2869901A
(en)
|
2000-02-04 |
2001-08-14 |
Lipoxen Technologies Limited |
Liposomes
|
US7892586B2
(en)
|
2001-02-22 |
2011-02-22 |
Suzanne Jaffe Stillman |
Water containing soluble fiber
|
US8178150B2
(en)
|
2000-02-22 |
2012-05-15 |
Suzanne Jaffe Stillman |
Water containing soluble fiber
|
US7115297B2
(en)
*
|
2000-02-22 |
2006-10-03 |
Suzanne Jaffe Stillman |
Nutritionally fortified liquid composition with added value delivery systems/elements/additives
|
JP2001316297A
(ja)
*
|
2000-02-23 |
2001-11-13 |
Kaken Pharmaceut Co Ltd |
遺伝子包埋リポソーム製剤及びその製法
|
US8642051B2
(en)
|
2000-03-21 |
2014-02-04 |
Suzanne Jaffe Stillman |
Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
|
CA2401593C
(en)
|
2000-03-21 |
2010-06-22 |
Suzanne Jaffe Stillman |
Infusion packet with useful and decorative elements, support member, delivery system and method
|
US7309581B2
(en)
*
|
2000-11-01 |
2007-12-18 |
Sysmex Corporation |
Method of staining, detection and counting bacteria, and a diluent for bacterial stain
|
DE60134265D1
(de)
*
|
2000-12-01 |
2008-07-10 |
Biomira Inc |
Herstellung grosser liposome durch infusion in peg
|
US7127357B1
(en)
|
2000-12-08 |
2006-10-24 |
The Salk Institute For Biological Studies |
Crystal structure of WW domains and methods of use thereof
|
US20070021360A1
(en)
*
|
2001-04-24 |
2007-01-25 |
Nyce Jonathan W |
Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase
|
EP1423095B1
(de)
*
|
2001-08-14 |
2016-09-28 |
Tel Aviv University Future Technology Development L.P. |
Lipidierte glycosaminoglycan-teilchen und ihre verwendung bei der arzneimittel- und genabgabe zur diagnose und therapie
|
WO2003018018A2
(en)
*
|
2001-08-24 |
2003-03-06 |
Neopharm, Inc. |
Vinorelbine compositions and methods of use
|
CA2485942A1
(en)
|
2002-05-31 |
2003-12-11 |
Cornell Research Foundation, Inc. |
Universal biosensor and methods of use
|
DE60329497D1
(de)
*
|
2002-06-26 |
2009-11-12 |
Medigene Ag |
Herstellung einer kationisch liposomalen zubereitung, einen lipophilen wirkstoff enthaltend
|
US7879351B2
(en)
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
CN1747738B
(zh)
*
|
2002-10-29 |
2010-11-24 |
川塞夫有限公司 |
缓释抗感染剂
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
EP1599183A2
(de)
*
|
2002-11-26 |
2005-11-30 |
Gilead Sciences, Inc. |
Verfahren zur arzneimittelladung von liposomen durch gradient.
|
US8980310B2
(en)
*
|
2002-12-31 |
2015-03-17 |
Bharat Serums and Vaccines, Ltd. |
Non-pegylated long-circulating liposomes
|
CA2511464C
(en)
*
|
2002-12-31 |
2011-08-23 |
Bharat Serums & Vaccines Ltd. |
Non-pegylated long-circulating liposomes
|
KR20050105451A
(ko)
*
|
2003-02-03 |
2005-11-04 |
네오팜 인코포레이티드 |
안정한 멸균 여과가능한 리포좀 캡슐화 탁산 및 다른항종양제
|
KR20060015534A
(ko)
*
|
2003-04-25 |
2006-02-17 |
더 펜 스테이트 리서치 파운데이션 |
성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
|
NZ546521A
(en)
*
|
2003-09-29 |
2009-09-25 |
Topigen Pharma Inc |
Oligonucleotide compositions and methods for treating disease including inflammatory conditions
|
EP1547582A1
(de)
*
|
2003-12-23 |
2005-06-29 |
MediGene Oncology GmbH |
Methode zur Herstellung von lipidkomplexiertem Camptothecincarboxylat
|
AU2005251691A1
(en)
*
|
2004-05-17 |
2005-12-22 |
Tekmira Pharmaceuticals Corporation |
Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
|
US7749520B2
(en)
*
|
2004-07-07 |
2010-07-06 |
Statens Serum Institut |
Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
|
AU2005302255A1
(en)
*
|
2004-10-28 |
2006-05-11 |
Alza Corporation |
Lyophilized liposome formulations and method
|
JP2008518925A
(ja)
*
|
2004-10-29 |
2008-06-05 |
ネオファーム、インコーポレイティッド |
リポソーム製剤の製造プロセス
|
BRPI0517387A8
(pt)
|
2004-10-29 |
2017-07-11 |
Topigen Pharmaceuticals Inc |
Oligonucleotídeos anti-senso para o tratamento de alergia e proliferação de células neoplásicas
|
US7195150B2
(en)
*
|
2004-12-20 |
2007-03-27 |
Microsoft Corporation |
Real time data from server
|
US20080045575A1
(en)
*
|
2004-12-29 |
2008-02-21 |
Van Dyke Thomas E |
Delivery of H2 Antagonists
|
EP1676569A1
(de)
*
|
2004-12-30 |
2006-07-05 |
Pevion Biotech Ltd. |
Gefriertrocknung von Virosomen
|
US8221046B2
(en)
|
2005-02-25 |
2012-07-17 |
Johnson & Johnson Consumer Companies, Inc. |
Compositions containing amines and use thereof
|
WO2006103101A2
(en)
|
2005-03-31 |
2006-10-05 |
Julius-Maximilians-Universität Würzburg |
MEANS FOR THE INHIBITION OF ANTI-β1-ADRENERGIC RECEPTOR ANTIBODIES
|
AU2006242354B2
(en)
*
|
2005-04-29 |
2012-03-15 |
University Of Louisville Research Foundation, Inc. |
Cell-surface decoration with active agents
|
US8226975B2
(en)
|
2005-12-08 |
2012-07-24 |
Insmed Incorporated |
Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
|
US20140271782A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Dermazone Solutions, Inc. |
Method for preparing nanolipids with encapsulated alcohol
|
JP5600432B2
(ja)
|
2006-04-06 |
2014-10-01 |
インスメッド, インコーポレイテッド |
コアセルベート化誘導リポソーム被包法及びその調合物
|
KR20090035662A
(ko)
*
|
2006-05-19 |
2009-04-10 |
토피겐 파마슈티컬스 인코포레이티드 |
포스포디에스테라아제의 발현에 영향을 미치는 올리고누클레오티드
|
EP2537526A1
(de)
*
|
2006-06-01 |
2012-12-26 |
Institut de Cardiologie de Montréal |
Verfahren und Verbindung zur Behandlung von Klappenstenose
|
WO2008137717A1
(en)
*
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
WO2011084685A2
(en)
|
2009-12-17 |
2011-07-14 |
Children's Medical Center Corporation |
Saposin-a derived peptides and uses thereof
|
CA3056116A1
(en)
|
2007-06-22 |
2008-12-31 |
Randolph Watnick |
Methods and uses thereof of prosaposin
|
AU2008291296B2
(en)
|
2007-08-24 |
2014-02-06 |
Julius-Maximilians-Universitat Wurzburg |
Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies
|
US20090291132A1
(en)
*
|
2008-01-04 |
2009-11-26 |
Brian Charles Keller |
Enhanced delivery of antifungal agents
|
US20120100067A1
(en)
*
|
2008-04-04 |
2012-04-26 |
Medigene Ag |
Solubilisation Method
|
WO2009136965A1
(en)
*
|
2008-05-06 |
2009-11-12 |
Sequella, Inc. |
Compositions and methods comprising capuramycin analogues
|
CN102099474B
(zh)
|
2008-05-15 |
2014-05-28 |
托皮根药品公司 |
用于治疗炎症和赘生性细胞增殖的寡核苷酸
|
EP2123258A1
(de)
|
2008-05-23 |
2009-11-25 |
Liplasome Pharma A/S |
Liposomen zur Arzneimittelverabreichung
|
WO2010086337A1
(en)
|
2009-01-27 |
2010-08-05 |
Julius-Maximilians-Universität Würzburg |
Novel peptide-homologues for inhibiting beta1-adrenoceptor antibodies
|
CA2982157A1
(en)
|
2009-02-16 |
2010-08-19 |
Cerenis Therapeutics Holding Sa |
Apolipoprotein a-i mimics
|
US20100260830A1
(en)
*
|
2009-04-08 |
2010-10-14 |
Brian A Salvatore |
Liposomal Formulations of Tocopheryl Amides
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
DK177532B1
(en)
|
2009-09-17 |
2013-09-08 |
Bio Bedst Aps |
Medical use of sPLA2 hydrolysable liposomes
|
EP2480209A1
(de)
*
|
2009-09-23 |
2012-08-01 |
Indu Javeri |
Verfahren zur herstellung von liposomen mit docetaxel
|
US10143652B2
(en)
|
2009-09-23 |
2018-12-04 |
Curirx Inc. |
Methods for the preparation of liposomes
|
DK177529B1
(en)
*
|
2009-10-23 |
2013-09-08 |
Bio Bedst Aps |
Liposomes with improved storage stability
|
WO2011123525A1
(en)
*
|
2010-04-01 |
2011-10-06 |
The Regents Of The University Of California |
Forming an artificial cell with controlled membrane composition, asymmetry and contents
|
EP2394640A1
(de)
|
2010-05-21 |
2011-12-14 |
MediGene AG |
Verbesserte liposomale Formulierungen von lipophilen Verbindungen
|
EP2576813A1
(de)
|
2010-05-28 |
2013-04-10 |
Diagon Kft. |
Verfahren für die zweiphasige zubereitung von liposomen und anwendung dafür bei der herstellung von diagnostischen reagenzien
|
CN103200932A
(zh)
*
|
2010-06-23 |
2013-07-10 |
布莱特赛德创新有限公司 |
卵磷脂载体囊泡及其制备方法
|
CA2819635A1
(en)
|
2010-12-01 |
2012-06-07 |
Spinal Modulation, Inc. |
Directed delivery of agents to neural anatomy
|
JP5813011B2
(ja)
*
|
2010-12-27 |
2015-11-17 |
テルモ株式会社 |
リポソーム組成物およびその製造方法
|
EP3281640A1
(de)
|
2011-06-17 |
2018-02-14 |
President and Fellows of Harvard College |
Frizzled 2 als zielmolekül für therapeutische antikörper bei der behandlung von krebs
|
AU2012333134B2
(en)
|
2011-07-22 |
2017-05-25 |
John Paul Guilinger |
Evaluation and improvement of nuclease cleavage specificity
|
CN104114156A
(zh)
*
|
2011-10-21 |
2014-10-22 |
切拉托尔制药公司 |
冻干脂质体
|
EP4378534A3
(de)
|
2011-12-22 |
2024-08-07 |
Medizinische Universität Wien |
Cyclotide als immunsuppressive wirkstoffe
|
EP3560509B1
(de)
|
2011-12-22 |
2024-01-31 |
Children's Medical Center Corporation |
Aus saposin-a gewonnene peptide und verwendungen davon
|
US9737480B2
(en)
|
2012-02-06 |
2017-08-22 |
President And Fellows Of Harvard College |
ARRDC1-mediated microvesicles (ARMMs) and uses thereof
|
CN104203216A
(zh)
|
2012-02-17 |
2014-12-10 |
效思因公司 |
热敏纳米颗粒制剂及其制备方法
|
US9849086B2
(en)
|
2012-03-19 |
2017-12-26 |
Nanologix Research, Inc. |
Method and composition for treating cystitis
|
AU2013202595B2
(en)
|
2012-03-30 |
2016-04-21 |
Biogen Ma Inc. |
Methods for modulating Tau expression for reducing seizure and modifying a neurodegenerative syndrome
|
US9511155B2
(en)
|
2012-04-17 |
2016-12-06 |
Merrimack Pharmaceuticals, Inc. |
Compositions and methods for non-invasive imaging
|
AU2013250767A1
(en)
|
2012-04-18 |
2014-10-09 |
Quiet Therapeutics Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
EP4005576B1
(de)
|
2012-05-21 |
2023-12-13 |
Insmed Incorporated |
Systeme zur behandlung von lungenentzündungen
|
AU2013352259B2
(en)
|
2012-11-29 |
2018-06-14 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
US9644207B2
(en)
|
2013-03-14 |
2017-05-09 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating Tau expression
|
TWI657819B
(zh)
|
2013-07-19 |
2019-05-01 |
美商Ionis製藥公司 |
用於調節τ蛋白表現之組合物
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
US9068179B1
(en)
|
2013-12-12 |
2015-06-30 |
President And Fellows Of Harvard College |
Methods for correcting presenilin point mutations
|
US9895385B2
(en)
|
2014-05-15 |
2018-02-20 |
Insmed Incorporated |
Methods for treating pulmonary non-tuberculous mycobacterial infections
|
US9392814B2
(en)
|
2014-06-06 |
2016-07-19 |
Nicholas J. Singer |
Delivery system for drinks
|
JP2017520549A
(ja)
|
2014-06-26 |
2017-07-27 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
核酸の送達のためのリポソーム製剤
|
AU2015298571B2
(en)
|
2014-07-30 |
2020-09-03 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
UA123624C2
(uk)
|
2014-09-03 |
2021-05-05 |
Бьорінґер Інґельхайм Інтернаціональ Ґмбх |
Сполука, специфічна до іл-23а та фнп-альфа, та її застосування
|
US9816080B2
(en)
|
2014-10-31 |
2017-11-14 |
President And Fellows Of Harvard College |
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
|
US10487324B2
(en)
|
2015-02-25 |
2019-11-26 |
Washington University |
Methods to detect motor neuron disease comprising micro-RNAs
|
CA2982547A1
(en)
*
|
2015-04-13 |
2016-10-20 |
Fountain Technologies International, Llc |
One-step method for production of ultra-small lipid structures
|
USD773313S1
(en)
|
2015-06-23 |
2016-12-06 |
Nicholas J. Singer |
Package
|
CN108135976B
(zh)
|
2015-07-23 |
2022-10-18 |
博灵格英格尔海姆国际股份公司 |
靶向il-23a和b细胞激活因子(baff)的化合物和其用途
|
WO2017070632A2
(en)
|
2015-10-23 |
2017-04-27 |
President And Fellows Of Harvard College |
Nucleobase editors and uses thereof
|
US10435682B2
(en)
|
2016-02-19 |
2019-10-08 |
University Of South Florida |
Arginine deiminase gene therapy for disordered proteins
|
AU2017277905B2
(en)
|
2016-06-08 |
2022-04-14 |
Children's Medical Center Corporation |
Engineered Botulinum neurotoxins
|
ES2939001T3
(es)
|
2016-07-08 |
2023-04-18 |
Childrens Medical Center |
Una neurotoxina botulínica novedosa y sus derivados
|
CA3032699A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harvard College |
Adenosine nucleobase editors and uses thereof
|
WO2018031683A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
JOP20190065A1
(ar)
|
2016-09-29 |
2019-03-28 |
Ionis Pharmaceuticals Inc |
مركبات وطرق لتقليل التعبير عن tau
|
EP3518981A4
(de)
|
2016-10-03 |
2020-06-10 |
President and Fellows of Harvard College |
Abgabe von therapeutischen rnas über arrdc1-vermittelte mikrovesikel
|
EP3526320A1
(de)
|
2016-10-14 |
2019-08-21 |
President and Fellows of Harvard College |
Aav-abgabe von nukleobasen-editoren
|
JP7456605B2
(ja)
|
2016-12-23 |
2024-03-27 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Pcsk9の遺伝子編集
|
US10745677B2
(en)
|
2016-12-23 |
2020-08-18 |
President And Fellows Of Harvard College |
Editing of CCR5 receptor gene to protect against HIV infection
|
AU2017258901A1
(en)
|
2016-12-30 |
2018-07-19 |
Allarity Therapeutics Europe ApS |
Methods for predicting drug responsiveness in cancer patients
|
EP3592853A1
(de)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Unterdrückung von schmerzen durch geneditierung
|
WO2018165631A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Cancer vaccine
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
KR102687373B1
(ko)
|
2017-03-23 |
2024-07-23 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
EP3658573A1
(de)
|
2017-07-28 |
2020-06-03 |
President and Fellows of Harvard College |
Verfahren und zusammensetzungen zur entwicklung von basiseditoren unter verwendung von phagenunterstützter kontinuierlicher entwicklung (pace)
|
WO2019139645A2
(en)
|
2017-08-30 |
2019-07-18 |
President And Fellows Of Harvard College |
High efficiency base editors comprising gam
|
EP3687566A2
(de)
|
2017-09-29 |
2020-08-05 |
Children's Medical Center Corporation |
Neurotoxinähnliches toxin und dessen verwendungen
|
CN111757937A
(zh)
|
2017-10-16 |
2020-10-09 |
布罗德研究所股份有限公司 |
腺苷碱基编辑器的用途
|
WO2019136310A2
(en)
|
2018-01-05 |
2019-07-11 |
University Of South Florida |
Novel compounds for the treatment of neurodegenerative diseases
|
WO2019168953A1
(en)
|
2018-02-27 |
2019-09-06 |
President And Fellows Of Harvard College |
Evolved cas9 variants and uses thereof
|
JP7460534B2
(ja)
|
2018-03-30 |
2024-04-02 |
インスメッド インコーポレイテッド |
リポソーム医薬品の連続製造方法
|
US10507226B1
(en)
|
2018-05-02 |
2019-12-17 |
University Of South Florida |
N-amino peptide beta-sheet mimics for the treatment of Alzheimer's disease
|
KR20210023833A
(ko)
|
2018-05-11 |
2021-03-04 |
빔 테라퓨틱스, 인크. |
프로그래밍가능한 염기 편집기 시스템을 이용하여 단일염기다형성을 편집하는 방법
|
WO2019226953A1
(en)
|
2018-05-23 |
2019-11-28 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
WO2020051360A1
(en)
|
2018-09-05 |
2020-03-12 |
The Broad Institute, Inc. |
Base editing for treating hutchinson-gilford progeria syndrome
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
US20220282275A1
(en)
|
2018-11-15 |
2022-09-08 |
The Broad Institute, Inc. |
G-to-t base editors and uses thereof
|
WO2020181178A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through thymine alkylation
|
WO2020181193A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenosine methylation
|
WO2020181195A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenine excision
|
WO2020181202A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to t:a base editing through adenine deamination and oxidation
|
WO2020181180A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to c:g base editors and uses thereof
|
WO2020191249A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
WO2020210751A1
(en)
|
2019-04-12 |
2020-10-15 |
The Broad Institute, Inc. |
System for genome editing
|
EP3956349A1
(de)
|
2019-04-17 |
2022-02-23 |
The Broad Institute, Inc. |
Adeninbaseneditoren mit reduzierten off-target-effekten
|
WO2020236982A1
(en)
|
2019-05-20 |
2020-11-26 |
The Broad Institute, Inc. |
Aav delivery of nucleobase editors
|
US20220315906A1
(en)
|
2019-08-08 |
2022-10-06 |
The Broad Institute, Inc. |
Base editors with diversified targeting scope
|
WO2021030666A1
(en)
|
2019-08-15 |
2021-02-18 |
The Broad Institute, Inc. |
Base editing by transglycosylation
|
US20230279373A1
(en)
|
2019-09-09 |
2023-09-07 |
Beam Therapeutics Inc. |
Novel crispr enzymes, methods, systems and uses thereof
|
WO2021072328A1
(en)
|
2019-10-10 |
2021-04-15 |
The Broad Institute, Inc. |
Methods and compositions for prime editing rna
|
US20230086199A1
(en)
|
2019-11-26 |
2023-03-23 |
The Broad Institute, Inc. |
Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
|
EP4069838A1
(de)
|
2019-12-03 |
2022-10-12 |
Beam Therapeutics Inc. |
Synthetische guide-rna, zusammensetzungen, verfahren und verwendungen davon
|
EP4097124A1
(de)
|
2020-01-28 |
2022-12-07 |
The Broad Institute Inc. |
Baseneditoren, zusammensetzungen und verfahren zur modifizierung des mitochondrialen genoms
|
WO2021158999A1
(en)
|
2020-02-05 |
2021-08-12 |
The Broad Institute, Inc. |
Gene editing methods for treating spinal muscular atrophy
|
US20230235309A1
(en)
|
2020-02-05 |
2023-07-27 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
AU2021238781A1
(en)
|
2020-03-20 |
2022-10-06 |
Medizinische Universität Wien |
Cyclotides in combination with kappa opioid receptor ligands for MS therapy
|
WO2021222318A1
(en)
|
2020-04-28 |
2021-11-04 |
The Broad Institute, Inc. |
Targeted base editing of the ush2a gene
|
MX2022014008A
(es)
|
2020-05-08 |
2023-02-09 |
Broad Inst Inc |
Métodos y composiciones para la edición simultánea de ambas cadenas de una secuencia de nucleótidos de doble cadena objetivo.
|
US20240067947A1
(en)
|
2020-10-28 |
2024-02-29 |
Children's Medical Center Corporation |
Truncated modified recombinant adamts13 and uses thereof
|
EP4263825A1
(de)
|
2021-02-19 |
2023-10-25 |
Beam Therapeutics, Inc. |
Rekombinante tollwutviren für gentherapie
|
EP4314265A2
(de)
|
2021-03-23 |
2024-02-07 |
Beam Therapeutics Inc. |
Neuartige crispr-enzyme, verfahren, systeme und verwendungen davon
|
AU2022256513A1
(en)
|
2021-04-16 |
2023-11-02 |
Beam Therapeutics Inc. |
Genetic modification of hepatocytes
|
US20240287487A1
(en)
|
2021-06-11 |
2024-08-29 |
The Broad Institute, Inc. |
Improved cytosine to guanine base editors
|
EP4373931A1
(de)
|
2021-07-23 |
2024-05-29 |
Beam Therapeutics Inc. |
Guide-rnas für crispr/cas-editiersysteme
|
US20230270840A1
(en)
|
2021-09-08 |
2023-08-31 |
Beam Therapeutics Inc. |
Viral guide rna delivery
|
WO2023076898A1
(en)
|
2021-10-25 |
2023-05-04 |
The Broad Institute, Inc. |
Methods and compositions for editing a genome with prime editing and a recombinase
|
EP4426832A1
(de)
|
2021-11-03 |
2024-09-11 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Genaue genomeditierung mit retrons
|
CA3238700A1
(en)
|
2021-11-23 |
2022-11-23 |
Philippe Duchateau |
New tale protein scaffolds with improved on-target/off-target activity ratios
|
GB202409668D0
(en)
|
2021-12-03 |
2024-08-14 |
Broad Inst Inc |
Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
|
IL312889A
(en)
|
2021-12-03 |
2024-07-01 |
Harvard College |
Self-assembling virus-like particles for delivery of nucleic acid programmable fusion proteins and methods for their preparation and use
|
AU2022413670A1
(en)
|
2021-12-17 |
2024-07-04 |
Beam Therapeutics Inc. |
Crispr enzymes, methzods, systems and uses thereof
|
WO2023196772A1
(en)
|
2022-04-04 |
2023-10-12 |
Beam Therapeutics Inc. |
Novel rna base editing compositions, systems, methods and uses thereof
|
WO2023196802A1
(en)
|
2022-04-04 |
2023-10-12 |
The Broad Institute, Inc. |
Cas9 variants having non-canonical pam specificities and uses thereof
|
WO2023205687A1
(en)
|
2022-04-20 |
2023-10-26 |
The Broad Institute, Inc. |
Improved prime editing methods and compositions
|
WO2023212715A1
(en)
|
2022-04-28 |
2023-11-02 |
The Broad Institute, Inc. |
Aav vectors encoding base editors and uses thereof
|
WO2023230613A1
(en)
|
2022-05-27 |
2023-11-30 |
The Broad Institute, Inc. |
Improved mitochondrial base editors and methods for editing mitochondrial dna
|
WO2023240137A1
(en)
|
2022-06-08 |
2023-12-14 |
The Board Institute, Inc. |
Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
|
WO2024040083A1
(en)
|
2022-08-16 |
2024-02-22 |
The Broad Institute, Inc. |
Evolved cytosine deaminases and methods of editing dna using same
|
WO2024059791A1
(en)
|
2022-09-16 |
2024-03-21 |
Beam Therapeutics Inc. |
Large serine recombinases, systems and uses thereof
|
WO2024077267A1
(en)
|
2022-10-07 |
2024-04-11 |
The Broad Institute, Inc. |
Prime editing methods and compositions for treating triplet repeat disorders
|
WO2024138087A2
(en)
|
2022-12-23 |
2024-06-27 |
The Broad Institute, Inc. |
Methods and compositions for modulating cellular factors to increase prime editing efficiencies
|
WO2024155745A1
(en)
|
2023-01-18 |
2024-07-25 |
The Broad Institute, Inc. |
Base editing-mediated readthrough of premature termination codons (bert)
|
WO2024155741A1
(en)
|
2023-01-18 |
2024-07-25 |
The Broad Institute, Inc. |
Prime editing-mediated readthrough of premature termination codons (pert)
|
WO2024168147A2
(en)
|
2023-02-09 |
2024-08-15 |
The Broad Institute, Inc. |
Evolved recombinases for editing a genome in combination with prime editing
|